Brian M.J. Cantwell

638 total citations
21 papers, 369 citations indexed

About

Brian M.J. Cantwell is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Brian M.J. Cantwell has authored 21 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Brian M.J. Cantwell's work include Cancer Treatment and Pharmacology (5 papers), Neuroendocrine Tumor Research Advances (4 papers) and Lung Cancer Research Studies (4 papers). Brian M.J. Cantwell is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Neuroendocrine Tumor Research Advances (4 papers) and Lung Cancer Research Studies (4 papers). Brian M.J. Cantwell collaborates with scholars based in United Kingdom, Australia and Norway. Brian M.J. Cantwell's co-authors include Adrian L. Harris, Michael Millward, James Carmichael, Ernst A. Lien, R.D. Rubens, John F. Stewart, R. Knight, Michael Minton, Paul A. Corris and C.R. Franks and has published in prestigious journals such as Cancer, European Journal of Cancer and Breast Cancer Research and Treatment.

In The Last Decade

Brian M.J. Cantwell

21 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian M.J. Cantwell United Kingdom 12 236 126 83 51 46 21 369
M Namer France 12 271 1.1× 94 0.7× 116 1.4× 84 1.6× 31 0.7× 36 442
V. Barbounis Greece 15 231 1.0× 102 0.8× 115 1.4× 85 1.7× 25 0.5× 31 481
S. C. Remick United States 9 244 1.0× 145 1.2× 76 0.9× 56 1.1× 32 0.7× 28 421
J.P. Bergerat France 10 192 0.8× 72 0.6× 88 1.1× 103 2.0× 14 0.3× 29 318
F. Majois Belgium 9 224 0.9× 56 0.4× 69 0.8× 59 1.2× 40 0.9× 28 350
Šárka Svobodová Czechia 13 132 0.6× 75 0.6× 61 0.7× 45 0.9× 42 0.9× 27 299
D. P. Ryan United States 13 241 1.0× 94 0.7× 180 2.2× 83 1.6× 44 1.0× 31 510
P. C. Hoffman United States 7 161 0.7× 235 1.9× 87 1.0× 35 0.7× 26 0.6× 16 488
T. Giannakakis Greece 13 367 1.6× 79 0.6× 90 1.1× 121 2.4× 60 1.3× 24 457
Julia Phillipson United States 10 145 0.6× 174 1.4× 165 2.0× 92 1.8× 24 0.5× 16 463

Countries citing papers authored by Brian M.J. Cantwell

Since Specialization
Citations

This map shows the geographic impact of Brian M.J. Cantwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian M.J. Cantwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian M.J. Cantwell more than expected).

Fields of papers citing papers by Brian M.J. Cantwell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian M.J. Cantwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian M.J. Cantwell. The network helps show where Brian M.J. Cantwell may publish in the future.

Co-authorship network of co-authors of Brian M.J. Cantwell

This figure shows the co-authorship network connecting the top 25 collaborators of Brian M.J. Cantwell. A scholar is included among the top collaborators of Brian M.J. Cantwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian M.J. Cantwell. Brian M.J. Cantwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Millward, Michael, David R. Newell, Kally Yuen, et al.. (1995). Pharmacokinetics and pharmacodynamics of prolonged oral etoposide in women with metastatic breast cancer. Cancer Chemotherapy and Pharmacology. 37(1-2). 161–167. 18 indexed citations
2.
Newell, David R., Kally Yuen, Jane Matthews, et al.. (1995). Pharmacokinetics and pharmacodynamics of prolonged oral etoposide in women with metastatic breast cancer. Cancer Chemotherapy and Pharmacology. 37(1-2). 161–167. 2 indexed citations
3.
Millward, Michael, Ernst A. Lien, Angela Byun Robinson, & Brian M.J. Cantwell. (1994). High-Dose (480 mg/day) Tamoxifen with Etoposide: A Study of a Potential Multi-Drug Resistance Modulator. Oncology. 51(1). 79–83. 22 indexed citations
4.
Millward, Michael, Michael Lind, Lindsey Gumbrell, et al.. (1994). Results of chemotherapy using ifosfamide with doxorubicin in advanced breast cancer. Breast Cancer Research and Treatment. 29(3). 271–277. 4 indexed citations
5.
Cantwell, Brian M.J., et al.. (1992). Metastatic Breast Cancer Presenting with Diabetes Insipidus. Acta Oncologica. 31(6). 679–680. 6 indexed citations
6.
Millward, Michael, Brian M.J. Cantwell, Ernst A. Lien, James Carmichael, & Adrian L. Harris. (1992). Intermittent high-dose tamoxifen as a potential modifier of multidrug resistance. European Journal of Cancer. 28(4-5). 805–810. 47 indexed citations
7.
Millward, Michael, Adrian L. Harris, & Brian M.J. Cantwell. (1990). Phase II study of doxorubicin plus ifosfamide/mesna in patients with advanced breast cancer. Cancer. 65(11). 2421–2425. 20 indexed citations
8.
Carmichael, James, Brian M.J. Cantwell, Adrian L. Harris, et al.. (1990). Assessment of renal toxicity by urinary enzymes in patients receiving chemotherapy with 8-methyl-8-acetylenic-putrescine. Cancer Chemotherapy and Pharmacology. 26(1). 65–66. 3 indexed citations
9.
Harris, Adrian L., James Carmichael, Brian M.J. Cantwell, & Mitch Dowsett. (1989). Zoladex: Therapeutic Effects in Postmenopausal Breast Cancer. Hormone Research. 32(1). 213–217. 6 indexed citations
10.
Cantwell, Brian M.J., James Carmichael, Kathryn Mannix, & Adrian L. Harris. (1989). Chemotherapy induced emesis may exacerbate the nephrotoxicity of combined ifosfamide/mesna and cisplatin chemotherapy. European Journal of Cancer and Clinical Oncology. 25(5). 917–918. 2 indexed citations
11.
Mannix, Kathryn, et al.. (1989). Single high-dose (45 mg) infusions of aminohydroxypropylidene diphosphonate for severe malignant hypercalcemia. Cancer. 64(6). 1358–1361. 14 indexed citations
12.
Carmichael, James, Brian M.J. Cantwell, & Adrian L. Harris. (1989). A phase II trial of ifosfamide/mesna with doxorubicin for malignant mesothelioma. European Journal of Cancer and Clinical Oncology. 25(5). 911–912. 26 indexed citations
13.
Harris, Adrian L., et al.. (1989). Phase II study of low dose aminoglutethimide 250 mg/day plus hydrocortisone in advanced postmenopausal breast cancer. European Journal of Cancer and Clinical Oncology. 25(7). 1105–1111. 13 indexed citations
14.
Cantwell, Brian M.J., et al.. (1989). Cisplatin with high-dose infusions of hydroxyurea to inhibit DNA repair. Cancer Chemotherapy and Pharmacology. 23(4). 252–254. 10 indexed citations
15.
Cantwell, Brian M.J., et al.. (1988). The multidrug resistant phenotype in clinical practice; evaluation of cross resistance to ifosfamide and mesna after VP16–213, doxorubicin and vincristine (VPAV) for small cell lung cancer. European Journal of Cancer and Clinical Oncology. 24(2). 123–129. 35 indexed citations
16.
Cantwell, Brian M.J., Valentine M. Macaulay, Adrian L. Harris, et al.. (1988). Phase II study of the antifolate N10-propargyl-5,8-dideazafolic acid (CB 3717) in advanced breast cancer. European Journal of Cancer and Clinical Oncology. 24(4). 733–736. 36 indexed citations
17.
Cantwell, Brian M.J., et al.. (1986). False-positive ketonuria during ifosfamide and mesna therapy. European Journal of Cancer and Clinical Oncology. 22(2). 229–230. 6 indexed citations
18.
Cantwell, Brian M.J., C.R. Franks, & Adrian L. Harris. (1986). A phase II study of the platinum analogues JM8 and JM9 in malignant pleural mesothelioma. Cancer Chemotherapy and Pharmacology. 18(3). 286–8. 18 indexed citations
19.
Powderly, William G., et al.. (1985). Renal glomerulopathies associated with Hodgkin's disease. Cancer. 56(4). 874–875. 15 indexed citations
20.
Cantwell, Brian M.J., Richard H. J. Beǵent, & R.D. Rubens. (1979). Augmentation of vincristine-induced thrombocytosis by norethisterone. European Journal of Cancer (1965). 15(8). 1065–1069. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Namer Breakdown of academic impact, for papers by V. Barbounis Breakdown of academic impact, for papers by S. C. Remick Breakdown of academic impact, for papers by J.P. Bergerat Breakdown of academic impact, for papers by F. Majois Breakdown of academic impact, for papers by Šárka Svobodová Breakdown of academic impact, for papers by D. P. Ryan Breakdown of academic impact, for papers by P. C. Hoffman Breakdown of academic impact, for papers by T. Giannakakis Breakdown of academic impact, for papers by Julia Phillipson
Rankless by CCL
2026